Literature DB >> 26989355

Current Status and Future Projections of Breast Cancer in Asia.

Lei Fan1, Paul E Goss2, Kathrin Strasser-Weippl3.   

Abstract

Asia is the world's largest continent comprising about 3/5 of the human population. Breast cancer is the most common type of cancer and the second leading cause of cancer-related deaths among women in Asia, accounting for 39% of all breast cancers diagnosed worldwide. The incidence of breast cancer in Asia varies widely across the continent and is still lower than in Western countries, but the proportional contribution of Asia to the global breast cancer rates is increasing rapidly in parallel to the socioeconomic development. However, the mortality-to-incidence ratios are much higher for Asia than for Western countries. Most Asian countries are low- and middle-income countries (LMICs) where breast cancer presents at a younger age and a later stage, and where patients are more likely to die from the disease than those in Western countries. Moreover, diagnostic workup, treatment and palliative services are inadequate in most Asian LMICs. In this review, we present an overview of the breast cancer risk factors and epidemiology, control measures, and cancer care among Asian countries.

Entities:  

Keywords:  Asia; Breast cancer; Epidemiology; Incidence; Screening

Year:  2015        PMID: 26989355      PMCID: PMC4789872          DOI: 10.1159/000441818

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  69 in total

1.  Recognising symptoms of breast cancer as a reason for delayed presentation in Asian women--the psycho-socio-cultural model for breast symptom appraisal: opportunities for intervention.

Authors:  Nur Aishah Taib; Cheng-Har Yip; Wah-Yun Low
Journal:  Asian Pac J Cancer Prev       Date:  2011

2.  Breast cancer: five-year survival in Srinagarind Hospital, Thailand.

Authors:  Potchavit Aphinives; Suriya Punchai; Damnern Vajirodom; Vajarabhongsa Bhudhisawasdi
Journal:  J Med Assoc Thai       Date:  2010-03

Review 3.  Cancer epidemiology in South Asia - past, present and future.

Authors:  Malcolm A Moore; Yasantha Ariyaratne; Farhana Badar; Yasmin Bhurgri; Karabi Datta; Aleyamma Mathew; Paleth Gangadharan; A Nandakumar; Kishore K Pradhananga; Md Habibullah Talukder; Balkrishna B Yeole; Tomotaka Sobue
Journal:  Asian Pac J Cancer Prev       Date:  2010

Review 4.  Cancer epidemiology in mainland South-East Asia - past, present and future.

Authors:  Malcolm A Moore; Pattarawin Attasara; Thiravud Khuhaprema; Tran Ngoan Le; Thi Hoai Nga Nguyen; Prak Piseth Raingsey; Supannee Sriamporn; Hutcha Sriplung; Petcharin Srivanatanakul; Duc Tung Bui; Surapon Wiangnon; Tomotaka Sobue
Journal:  Asian Pac J Cancer Prev       Date:  2010

5.  Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Authors:  Claudia Allemani; Hannah K Weir; Helena Carreira; Rhea Harewood; Devon Spika; Xiao-Si Wang; Finian Bannon; Jane V Ahn; Christopher J Johnson; Audrey Bonaventure; Rafael Marcos-Gragera; Charles Stiller; Gulnar Azevedo e Silva; Wan-Qing Chen; Olufemi J Ogunbiyi; Bernard Rachet; Matthew J Soeberg; Hui You; Tomohiro Matsuda; Magdalena Bielska-Lasota; Hans Storm; Thomas C Tucker; Michel P Coleman
Journal:  Lancet       Date:  2014-11-26       Impact factor: 79.321

Review 6.  Management of breast cancer in Nepal.

Authors:  Y P Singh; P Sayami
Journal:  JNMA J Nepal Med Assoc       Date:  2009 Jul-Sep       Impact factor: 0.406

Review 7.  Breast cancer in China.

Authors:  Lei Fan; Kathrin Strasser-Weippl; Jun-Jie Li; Jessica St Louis; Dianne M Finkelstein; Ke-Da Yu; Wan-Qing Chen; Zhi-Ming Shao; Paul E Goss
Journal:  Lancet Oncol       Date:  2014-06       Impact factor: 41.316

Review 8.  Myelodysplastic syndrome associated with bone marrow fibrosis.

Authors:  G Lambertenghi-Deliliers; C Annaloro; A Oriani; D Soligo
Journal:  Leuk Lymphoma       Date:  1992-09

9.  Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China.

Authors:  Lei Fan; Ying Zheng; Ke-Da Yu; Guang-Yu Liu; Jiong Wu; Jin-Song Lu; Kun-Wei Shen; Zhen-Zhou Shen; Zhi-Ming Shao
Journal:  Breast Cancer Res Treat       Date:  2009-01-20       Impact factor: 4.872

10.  Oncology in Nepal.

Authors:  Madan K Piya; Sandhya C Acharya
Journal:  South Asian J Cancer       Date:  2012-07
View more
  28 in total

1.  Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study.

Authors:  Rabeb M Ghali; Maryam A Al-Mutawa; Bashayer H Ebrahim; Hanen H Jrah; Sonia Zaied; Hanen Bhiri; Fahmi Hmila; Touhami Mahjoub; Wassim Y Almawi
Journal:  Pathol Oncol Res       Date:  2018-01-04       Impact factor: 3.201

2.  Sentinel Lymph Node Mapping in Breast Cancer: Initial Experience of a Multidisciplinary Team.

Authors:  Tahira Yasmin; Muhammad Numair Younis; Misbah Masood; Huma Majeed Khan; Zahid Asgher; Abubaker Shahid
Journal:  Cureus       Date:  2022-06-16

3.  Economic evaluations of mammography to screen for breast cancer in low- and middle-income countries: A systematic review.

Authors:  Ajeng V Icanervilia; Jurjen van der Schans; Qi Cao; Adriana C de Carvalho; Kathya Cordova-Pozo; Jarir At Thobari; Maarten J Postma; Antoinette DI van Asselt
Journal:  J Glob Health       Date:  2022-07-16       Impact factor: 7.664

Review 4.  Potential Pro-Tumorigenic Effect of Bisphenol A in Breast Cancer via Altering the Tumor Microenvironment.

Authors:  Youngjoo Kwon
Journal:  Cancers (Basel)       Date:  2022-06-19       Impact factor: 6.575

5.  Fluorescence in situ hybridisation analysis of human epidermal growth factor receptor 2 status for breast cancer cases in Brunei Darussalam.

Authors:  Jessica Pei Chii Kok; Mas Rina Wati Haji Abdul Hamid; Ravi Sekhar Patnaik; Kenneth Yuh Yen Kok
Journal:  Cancer Rep (Hoboken)       Date:  2020-06-08

Review 6.  Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options.

Authors:  Flavia Zita Francies; Rodney Hull; Richard Khanyile; Zodwa Dlamini
Journal:  Am J Cancer Res       Date:  2020-05-01       Impact factor: 5.942

7.  Co-expression and significance of Dok2 and Ras p21 protein activator 1 in breast cancer.

Authors:  Jiangrong Huang; Xiaochun Peng; Kun Zhang; Chunyan Li; Bo Su; Yanxiang Zhang; Wangui Yu
Journal:  Oncol Lett       Date:  2017-08-28       Impact factor: 2.967

8.  miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer.

Authors:  Fangliang Yang; Yuan Li; Lingyun Xu; Yulan Zhu; Haiyan Gao; Lin Zhen; Lin Fang
Journal:  Onco Targets Ther       Date:  2017-01-27       Impact factor: 4.147

9.  The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian origin.

Authors:  Dinesh Chandra Doval; Anurag Mehta; S P Somashekhar; Aparna Gunda; Gurpreet Singh; Amanjit Bal; Siddhant Khare; Chandra Prakash V Serkad; Manjula Adinarayan; Naveen Krishnamoorthy; Devanhalli Govinda Vijay; Radha Anantakrishnan; G S Bhattacharyya; Manjiri M Bakre
Journal:  Breast       Date:  2021-05-28       Impact factor: 4.380

10.  A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway.

Authors:  Wei Liang; Junfeng Shi; Haiyan Xia; Xiaowei Wei
Journal:  Oxid Med Cell Longev       Date:  2021-06-07       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.